Baumann, Michael, 1962-
Baumann, Michael (Cancérologue)
Baumann, Michael (Oncologist)
Baumann, Michael, 19..-...., oncologue
Michael Baumann deutscher Mediziner
VIAF ID: 100338759 ( Personal )
Permalink: http://viaf.org/viaf/100338759
Preferred Forms
4xx's: Alternate Name Forms (5)
5xx's: Related Names (7)
- 510 2 _ ‡a Deutsche Akademie der Naturforscher Leopoldina ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Deutsches Krebsforschungszentrum ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Dresden ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Helmholtz-Zentrum Dresden-Rossendorf ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universität Heidelberg ‡b Medizinische Fakultät ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Westerstede ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
Title | Sources |
---|---|
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models | |
Be smart against cancer! A school-based program covering cancer-related risk behavior | |
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic | |
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) | |
Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets | |
Molecular Radio-Oncology | |
Neue Verfahren der Präzisions-Strahlentherapie | |
A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT | |
Oxford textbook of oncology | |
Präklinische und translationale Strahlentherapie und personalisierte Medizin: -omics | |
Proceedings des 13. Symposiums Experimentelle Strahlentherapie und Klinische Strahlenbiologie Dresden, 4. - 6. März 2004 | |
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) | |
value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts |